Long-Term Follow-Up of a Pediatric Cohort With Short QT Syndrome

Objectives The purpose of this study was to define the clinical characteristics and long-term follow-up of pediatric patients with short QT syndrome (SQTS). Background SQTS is associated with sudden cardiac death. The clinical characteristics and long-term prognosis in young patients have not been r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2013-03, Vol.61 (11), p.1183-1191
Hauptverfasser: Villafañe, Juan, MD, Atallah, Joseph, MD, CM, SM, Gollob, Michael H., MD, Maury, Philippe, MD, Wolpert, Christian, MD, Gebauer, Roman, MD, Watanabe, Hiroshi, MD, PhD, Horie, Minoru, MD, Anttonen, Olli, MD, PhD, Kannankeril, Prince, MD, Faulknier, Brett, DO, Bleiz, Jorge, MD, Makiyama, Takeru, MD, PhD, Shimizu, Wataru, MD, PhD, Hamilton, Robert M., MD, Young, Ming-Lon, MD, MPH
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives The purpose of this study was to define the clinical characteristics and long-term follow-up of pediatric patients with short QT syndrome (SQTS). Background SQTS is associated with sudden cardiac death. The clinical characteristics and long-term prognosis in young patients have not been reported. Methods This was an international case series involving 15 centers. Patients were analyzed for electrocardiography characteristics, genotype, clinical events, Gollob score, and efficacy of medical or defibrillator (implantable cardioverter-defibrillator [ICD]) therapy. To assess the possible prognostic value of the Gollob score, we devised a modified Gollob score that excluded clinical events from the original score. Results Twenty-five patients 21 years of age or younger (84% males, median age: 15 years, interquartile range: 9 to 18 years) were followed up for 5.9 years (interquartile range: 4 to 7.1 years). Median corrected QT interval for heart rate was 312 ms (range: 194 to 355 ms). Symptoms occurred in 14 (56%) of 25 patients and included aborted sudden cardiac death in 6 patients (24%) and syncope in 4 patients (16%). Arrhythmias were common and included atrial fibrillation (n = 4), ventricular fibrillation (n = 6), supraventricular tachycardia (n = 1), and polymorphic ventricular tachycardia (n = 1). Sixteen patients (84%) had a familial or personal history of cardiac arrest. A gene mutation associated with SQTS was identified in 5 (24%) of 21 probands. Symptomatic patients had a higher median modified Gollob score (excluding points for clinical events) compared with asymptomatic patients (5 vs. 4, p = 0.044). Ten patients received medical treatment, mainly with quinidine. Eleven of 25 index cases underwent ICD implantation. Two patients had appropriate ICD shocks. Inappropriate ICD shocks were observed in 64% of patients. Conclusions SQTS is associated with aborted sudden cardiac death among the pediatric population. Asymptomatic patients with a Gollob score of
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2012.12.025